Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Electroretinogram in Duchenne/Becker muscular dystrophy

S I Pascual Pascual1, J Molano, I Pascual-Castroviejo

  • 1Service of Neuropediatrics, Hospital Infantil La Paz, Madrid, Spain.

Pediatric Neurology
|May 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidisciplinary management of X-linked myotubular myopathy in Spain and Portugal: A case series analysis.

Neurologia·2026
Same author

Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.

Neurologia·2024
Same author

Characterization of inflammatory bowel disease in Colombia: Results of a national register.

Revista de gastroenterologia de Mexico (English)·2020
Same author

Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.

Neurologia·2019
Same author

European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience.

European journal of neurology·2017
Same author

Mutational spectrum of Duchenne muscular dystrophy in Spain: Study of 284 cases.

Neurologia (Barcelona, Spain)·2016

Electroretinography (ERG) effectively detects functional abnormalities in dystrophinopathies. The B/A amplitude ratio is a key indicator, significantly differing between Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and controls.

Area of Science:

  • Neurology
  • Ophthalmology
  • Genetics

Background:

  • Dystrophinopathies, including Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD), are genetic neuromuscular disorders.
  • Accurate diagnosis and functional assessment are crucial for managing these progressive conditions.
  • Electroretinography (ERG) offers a non-invasive method to evaluate retinal function, which can be affected in certain neuromuscular diseases.

Purpose of the Study:

  • To assess the utility of electroretinography (ERG) in detecting functional abnormalities in patients with dystrophinopathies.
  • To determine the diagnostic value of the B-wave to A-wave amplitude ratio (B/A amplitude ratio) in differentiating between Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and carriers.
  • To correlate ERG findings with disease severity and genetic characteristics.

Related Experiment Videos

Main Methods:

  • Consecutive patients with dystrophinopathy underwent electroretinography (ERG) using skin eyelid electrodes and standard flash stimulation.
  • The B/A amplitude ratio was calculated and compared between patient groups (DMD, BMD, DMD carriers) and healthy controls.
  • Statistical analysis, including significance testing (P < 0.001), was performed on the ERG parameters.

Main Results:

  • The B/A amplitude ratio was significantly lower (< 2) in 100% of DMD patients and 71% of BMD patients compared to controls.
  • DMD carriers showed variable B/A amplitude ratios, with 50% having ratios less than 2.
  • ERG abnormalities correlated with more severe muscular phenotypes but not with specific gene deletion characteristics.

Conclusions:

  • Electroretinography (ERG) is a valuable, simple tool for diagnosing suspected dystrophinopathies when molecular studies are inconclusive.
  • The B/A amplitude ratio is a sensitive indicator for DMD and BMD, though less definitive for DMD carriers.
  • ERG findings provide functional insights that complement genetic and clinical assessments in dystrophinopathy management.